These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16265154)

  • 1. Is lamivudine a safe and effective therapy for patients with chronic hepatitis B and advanced liver disease?
    Karayiannis P; Thomas HC
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):138-9. PubMed ID: 16265154
    [No Abstract]   [Full Text] [Related]  

  • 2. Remission of hepatitis B virus-associated membranoproliferative glomerulonephritis in a cirrhotic patient after lamivudine therapy.
    Wen YK; Chen ML
    Clin Nephrol; 2006 Mar; 65(3):211-5. PubMed ID: 16550753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B.
    Tsubota A; Arase Y; Suzuki Y; Suzuki F; Sezaki H; Hosaka T; Akuta N; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kumada H
    J Gastroenterol Hepatol; 2005 Mar; 20(3):426-32. PubMed ID: 15740488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lamivudine treatment of patients with decompensated HBV cirrhosis and mutation in YMDD motif].
    Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):77-8. PubMed ID: 15670511
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of liver cirrhosis B resistant to lamivudine showing the clinical effect of adefovir dipivoxil].
    Sumida Y; Kanemasa K; Tachibana S; Maekawa K; Mori K; Minami M; Okanoue T
    Nihon Shokakibyo Gakkai Zasshi; 2004 May; 101(5):521-4. PubMed ID: 15168763
    [No Abstract]   [Full Text] [Related]  

  • 7. [Managing resistance to analogue antiviral drugs in a decompensated cirrhosis patient].
    Zarski JP
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S20-1. PubMed ID: 17075491
    [No Abstract]   [Full Text] [Related]  

  • 8. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B.
    Villeneuve JP; Condreay LD; Willems B; Pomier-Layrargues G; Fenyves D; Bilodeau M; Leduc R; Peltekian K; Wong F; Margulies M; Heathcote EJ
    Hepatology; 2000 Jan; 31(1):207-10. PubMed ID: 10613747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
    Lai CL; Chien RN; Leung NW; Chang TT; Guan R; Tai DI; Ng KY; Wu PC; Dent JC; Barber J; Stephenson SL; Gray DF
    N Engl J Med; 1998 Jul; 339(2):61-8. PubMed ID: 9654535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants.
    Marzano A; Lampertico P; Mazzaferro V; Carenzi S; Vigano M; Romito R; Pulvirenti A; Franchello A; Colombo M; Salizzoni M; Rizzetto M
    Liver Transpl; 2005 May; 11(5):532-8. PubMed ID: 15838891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study.
    Lampertico P; Invernizzi F; Viganò M; Loglio A; Mangia G; Facchetti F; Primignani M; Jovani M; Iavarone M; Fraquelli M; Casazza G; de Franchis R; Colombo M
    J Hepatol; 2015 Nov; 63(5):1118-25. PubMed ID: 26100495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lamivudine in the therapy of Nigerian patients with Chronic HBV infection.
    Ola SO; Udo UA; Ogunrin AO
    Niger Postgrad Med J; 2014 Dec; 21(4):294-8. PubMed ID: 25633447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?
    Cooksley G
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):12-3. PubMed ID: 16265091
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.
    Chan HL; Wong VW; Tse AM; Tse CH; Chim AM; Chan HY; Wong GL; Sung JJ
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1462-8. PubMed ID: 18054753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with response to lamivudine: Retrospective study in a tertiary care clinic serving patients with chronic hepatitis B.
    Hann HW; Jonsson Funk ML; Rosenberg DM; Davis R
    J Gastroenterol Hepatol; 2005 Mar; 20(3):433-40. PubMed ID: 15740489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis B infection.
    Omata M
    N Engl J Med; 1998 Jul; 339(2):114-5. PubMed ID: 9654543
    [No Abstract]   [Full Text] [Related]  

  • 17. Histological outcome during long-term lamivudine therapy.
    Dienstag JL; Goldin RD; Heathcote EJ; Hann HW; Woessner M; Stephenson SL; Gardner S; Gray DF; Schiff ER
    Gastroenterology; 2003 Jan; 124(1):105-17. PubMed ID: 12512035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
    Yuen MF; Seto WK; Chow DH; Tsui K; Wong DK; Ngai VW; Wong BC; Fung J; Yuen JC; Lai CL
    Antivir Ther; 2007; 12(8):1295-303. PubMed ID: 18240869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamivudine for chronic hepatitis B and HIV co-infection.
    Carton JA; Maradona JA; Asensi V; Rodríguez M; Martínez A
    AIDS; 1999 May; 13(8):1002-3. PubMed ID: 10371189
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
    Sponseller CA; Bacon BR; Di Bisceglie AM
    Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.